These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10894460)

  • 41. Endotracheal surfactant atomization: an alternative to bolus instillation?
    Wagner MH; Amthauer H; Sonntag J; Drenk F; Eichstädt HW; Obladen M
    Crit Care Med; 2000 Jul; 28(7):2540-4. PubMed ID: 10921591
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Surfactant effects on aerosolized and instilled adenoviral-mediated gene transfer.
    Jobe AH; Ikegami M; Yei S; Whitsett JA; Trapnell B
    Hum Gene Ther; 1996 Apr; 7(6):697-704. PubMed ID: 8919591
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protective effects of aerosolized pulmonary surfactant powder in a model of ventilator-induced lung injury.
    Daniher D; McCaig L; Ye Y; Veldhuizen R; Lewis J; Ma Y; Zhu J
    Int J Pharm; 2020 Jun; 583():119359. PubMed ID: 32334066
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surfactant nebulisation: safety, efficiency and influence on surface lowering properties and biochemical composition.
    Dijk PH; Heikamp A; Piers DA; Weller E; Bambang Oetomo S
    Intensive Care Med; 1997 Apr; 23(4):456-62. PubMed ID: 9142589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Importance of surface active substances in the lung].
    Kadlec K; Kandus J
    Vnitr Lek; 1972 Jun; 18(6):521-31. PubMed ID: 5068058
    [No Abstract]   [Full Text] [Related]  

  • 46. In vitro surfactant and perfluorocarbon aerosol deposition in a neonatal physical model of the upper conducting airways.
    Goikoetxea E; Murgia X; Serna-Grande P; Valls-i-Soler A; Rey-Santano C; Rivas A; Antón R; Basterretxea FJ; Miñambres L; Méndez E; Lopez-Arraiza A; Larrabe-Barrena JL; Gomez-Solaetxe MA
    PLoS One; 2014; 9(9):e106835. PubMed ID: 25211475
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antenatal modes of surfactant administration for RDS prevention: a review.
    Ostrzenski A; Radolinski B; Ostrzenska KM
    J Natl Med Assoc; 2006 Mar; 98(3):340-4. PubMed ID: 16573296
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Artificial surfactant to prevent and treat neonatal respiratory distress syndrome.
    Enhorning G
    Pediatrics; 1980 Nov; 66(5):799-800. PubMed ID: 7432889
    [No Abstract]   [Full Text] [Related]  

  • 49. [Ultrasonic atomization of surface-active agents from lung tissue and lecithin dispersions with reference to the artificial spraying of lungs].
    Winsel K; Bergmann KC; Lachmann B
    Z Erkr Atmungsorgane; 1974 Mar; 140(2):151-58. PubMed ID: 4496749
    [No Abstract]   [Full Text] [Related]  

  • 50. Proposal of selective wedge instillation of pulmonary surfactant for COVID-19 pneumonia based on computational fluid dynamics simulation.
    Kitaoka H; Kobayashi H; Takimoto T; Kijima T
    BMC Pulm Med; 2021 Feb; 21(1):62. PubMed ID: 33618696
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surfactant Driven Post-Deposition Spreading of Aerosols on Complex Aqueous Subphases. 2: Low Deposition Flux Representative of Aerosol Delivery to Small Airways.
    Sharma R; Khanal A; Corcoran TE; Garoff S; Przybycien TM; Tilton RD
    J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):394-405. PubMed ID: 25757067
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surfactant delivery in rat lungs: Comparing 3D geometrical simulation model with experimental instillation.
    Kazemi A; Louis B; Isabey D; Nieman GF; Gatto LA; Satalin J; Baker S; Grotberg JB; Filoche M
    PLoS Comput Biol; 2019 Oct; 15(10):e1007408. PubMed ID: 31622332
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spreading of exogenous surfactant in an airway.
    Espinosa FF; Shapiro AH; Fredberg JJ; Kamm RD
    J Appl Physiol (1985); 1993 Nov; 75(5):2028-39. PubMed ID: 8307856
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aerosolized Surfactants, Anti-Inflammatory Drugs, and Analgesics.
    Willson DF
    Respir Care; 2015 Jun; 60(6):774-90; discussion 790-3. PubMed ID: 26070574
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment of idiopathic respiratory distress syndrome--prospective method by artificial surfactant (author's transl)].
    Kobayashi T; Sada T; Murakami S
    Masui; 1979 Oct; 28(10):1012-7. PubMed ID: 513270
    [No Abstract]   [Full Text] [Related]  

  • 56. E-cigarette aerosol exposure of pulmonary surfactant impairs its surface tension reducing function.
    Graham E; McCaig L; Shui-Kei Lau G; Tejura A; Cao A; Zuo YY; Veldhuizen R
    PLoS One; 2022; 17(11):e0272475. PubMed ID: 36350850
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The roles of drug therapy given via the endotracheal tube to neonates.
    Greenough A; Papalexopoulou N
    Arch Dis Child Fetal Neonatal Ed; 2017 May; 102(3):F277-F281. PubMed ID: 28270430
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physiologic Effects of Instilled and Aerosolized Surfactant Using a Breath-Synchronized Nebulizer on Surfactant-Deficient Rabbits.
    DiBlasi RM; Micheletti KJ; Zimmerman JD; Poli JA; Fink JB; Kajimoto M
    Pharmaceutics; 2021 Sep; 13(10):. PubMed ID: 34683873
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A rat lung model of instilled liquid transport in the pulmonary airways.
    Cassidy KJ; Bull JL; Glucksberg MR; Dawson CA; Haworth ST; Hirschl R; Gavriely N; Grotberg JB
    J Appl Physiol (1985); 2001 May; 90(5):1955-67. PubMed ID: 11299290
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Presence of the surfactant system in the lung as a condition for recovery from upper respiratory tract diseases. I. Introduction].
    Wildeboer-Venema FN
    Ned Tijdschr Geneeskd; 1971 Aug; 115(35):1455-9. PubMed ID: 5109314
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.